Why the study?
Does poliomyelitis vaccination prevent paralytic poliomyelitis in the general population?
Does poliomyelitis vaccination prevent paralytic poliomyelitis in the general population?
The development of the poliomyelitis vaccine provides the first large-scale control measure to combat the paralytic form of the disease.
Answers are grounded in this paper and cite their sources.
Supports large-scale polio vaccination; leaves open durability against modern strains and variants.
Recent progress in poliomyelitis research has culminated, after a decade of work, in the development of a useful vaccine¹to combat paralysis. The vaccine is the first, and currently the only, control measure usable on a large scale that appears to provide substantial immunity against the paralytic form of this disease. Poliomyelitis is a nationwide health problem that has increased in size and significance in recent years. It is one of the few communicable diseases, in fact, that has shown a rise in both incidence and death rates in the United States during the past two decades. Nonetheless, the incidence of clinical poliomyelitis today is considerably less than that of many other infectious diseases. In 1954, the third highest year of reported poliomyelitis incidence in United States history, 38,741 cases of poliomyelitis (including both paralytic and nonparalytic cases) were reported to the Public Health Service. In the same year
No takes yet. Share an insight, caveat, or question.
Leonard A. Scheele (1955) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: